Advertisement
Screener

INTERPACE BIOSCIENCES, INC. (IDXG) Business Acquisition, Pro Forma Revenue

2.6 / 5 stars · 47/91 Roast Me

INTERPACE BIOSCIENCES, INC. Business Acquisition, Pro Forma Revenue

INTERPACE BIOSCIENCES, INC. (IDXG) reported Business Acquisition, Pro Forma Revenue of $31.72 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-04-01.

Discontinued › Income Statement › Other Income

us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2021-04-01

  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for the quarter ending 2019-12-31 was $4.07M, a 57.86% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for the quarter ending 2019-09-30 was $8.01M, a 17.77% decline year-over-year.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for the quarter ending 2018-12-31 was $9.67M.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for the quarter ending 2018-09-30 was $9.74M.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for fiscal 2019 was $31.72M, a 14.77% decline from fiscal 2018.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for fiscal 2018 was $37.22M.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for fiscal 2014 was $9.79M, a 93.96% decline from fiscal 2013.
  • INTERPACE BIOSCIENCES, INC. business acquisition, pro forma revenue for fiscal 2013 was $162.01M.
Period endBusiness Acquisition, Pro Forma Revenue 3 monthBusiness Acquisition, Pro Forma Revenue 6 monthBusiness Acquisition, Pro Forma Revenue 9 monthBusiness Acquisition, Pro Forma Revenue 12 monthBusiness Acquisition, Pro Forma Revenue 12 month as first filed
2019-12-31$4.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01
$12.08M
derived: sum of 2 quarters · filed 2021-04-01
$31.72M
10-K · filed 2021-04-01
2019-09-30$8.01M
10-Q · filed 2019-11-14
$27.65M
10-Q · filed 2019-11-14
2018-12-31$9.67M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19
$19.41M
derived: sum of 2 quarters · filed 2021-01-19
$37.22M
10-K/A · filed 2021-01-19
2018-09-30$9.74M
10-Q · filed 2019-11-14
$27.55M
10-Q · filed 2019-11-14
2014-12-31$9.79M
10-K · filed 2016-03-30
$128.25M
10-K · filed 2015-03-05
2013-12-31$162.01M
10-K · filed 2015-03-05